ISPE

APRIL 28, 2023

When Speed to Market Counts Trudy Patterson Fri, 04/28/2023 - 12:19 iSpeak Blog iSpeak When Speed to Market Counts David Doleski Laura-Ann Shaa Ling Chin, BSc, MSc, PE 28 April 2023 Speed to market is a major priority for life sciences companies and this is going to be a featured topic during the 2023 ISPE Biotechnology Conference.

98

98

European Pharmaceutical Review

OCTOBER 13, 2022

The first focus will be to improve how work related to COVID-19 is handled: interactions with regulators, prioritising topics, managing medicines with no marketing authorisation, planning for HTAs and economic modelling methods. The bodies will work collectively on scientific and methodological topics to address these difficulties.

Communication 89

Communication 89

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. As per this deal, Lilly will obtain access to further targets in the central nervous system and peripheral nervous system using the Axiomer platform. Free Whitepaper.

Communication 131

Communication 131

Pharmaceutical Technology

APRIL 27, 2023

The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. However, the reform has its share of critics.

Documentation 105

Documentation 105

Pharmaceutical Technology

JULY 18, 2022

Quoin Pharmaceuticals and Endo International subsidiary Endo Ventures have signed a licence and distribution agreement and a supply agreement to develop, register, supply, market and distribute the former’s QRX003 exclusively in Canada. A lead product of Quoin, QRX003 is a topical lotion intended to treat Netherton Syndrome.

64

64

Pharmaceutical Technology

DECEMBER 8, 2022

According to the revised deal, Daiichi Sankyo and Kite will transfer the Marketing Authorization for Yescarta to Gilead’s Japan subsidiary, Gilead Sciences K.K., The therapy’s sales and promotion works in Japan following the transfer of marketing authorisation will be carried out by the Kite Cell Therapy Business Unit at Gilead Sciences K.K.

Communication 122

Communication Immunization Hospitals 122

pharmaphorum

MARCH 15, 2022

With digital engagement rapidly overtaking traditional models, life science teams must equip themselves with a means to engage patients in a virtual setting that’s easy to access and available when they are. Marketing Permissions. We use Mailchimp as our marketing platform. Real-world examples of patient engagement success.

98

98

Pharmaceutical Technology

JUNE 12, 2023

Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription after the US Food and Drug Administration (FDA) greenlit Futura Medical’s Eroxon. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

FDA 52

FDA 52

Pharmaceutical Technology

MARCH 10, 2023

The representative expected the facility to open more treatment opportunities for UK citizens saying, “It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and bring new treatments into the NHS faster.”

Communication 105

Communication 105

Pharma Marketing Network

DECEMBER 6, 2021

Direct Integrations with hundreds of leading health websites provides Tap Native access to billions of content pages for analysis. NEW YORK, December 6 th , 2021 (PRNEWSWIRE) – Tap Native, the leading health-focused content discovery platform, today unveiled a list of the top 20 most popular health topics viewed by consumer audiences in 2021.

Immunization 52

Immunization Vaccines 52

ISPE

JUNE 23, 2023

Presentations will discuss harmonized approaches to advancements in drug development, design and equipment solutions, and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient and sustainable manner to improve patient health.

Pharmaceutical Companies 94

Pharmaceutical Companies Pharmaceutical Companies 94

ISPE

MAY 16, 2023

According to a report by Grand View Research, the global blockchain technology market in healthcare is expected to grow at a compound annual growth rate (CAGR) of 66.1% Below are just a few of the topics that we’ve covered recently. from 2021 to 2028.

Compounding 98

Compounding 98

Pharma Marketing Network

MARCH 25, 2022

5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. . Brand marketers who carve out a caregiver platform can determine specific education and support based on disease state and prognosis. Accessed March 21, 2022. Accessed March 12, 2022.

Labelling 98

Labelling FDA 98

Pharma Marketing Network

APRIL 5, 2023

Attending the Reuters Pharma Marketing 2023 event on March 28-29 was a fascinating experience as the pharma marketing industry continues to return to in-person events. Marketing and analytics teams’ collaboration is critical in building more data-driven omnichannel engagement of HCPs and patients.

52

52

European Pharmaceutical Review

JANUARY 29, 2024

During 2023, there were five revisions to the European Medicines Agency ’s (EMA’s) Questions and Answers (Q&As) for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. However, there were some notable differences.

FDA 103

FDA Vaccines Compounding 103

pharmaphorum

OCTOBER 18, 2022

It combines dexamethasone, an approved active ingredient proven as effective and safe in the treatment of DME, with Oculis’ novel formulation Optireach technology, which facilitates active ingredient access to the back of the eye. glaucoma), the OCS-05 proof-of-concept trial in acute optic neuritis.

58

58

Roots Analysis

AUGUST 17, 2023

Players Offering Blockchain in Drug Discovery and Clinical Trials Market Presently, over 50 companies are actively engaged in offering blockchain in drug discovery and clinical trials, worldwide. You can also download the SAMPLE REPORT on this topic by Roots Analysis by clicking on the link here.

52

52

European Pharmaceutical Review

DECEMBER 20, 2023

The proposed changes to EU pharmaceutical legislation broadly aim to: Support innovation and boost attractiveness of EU market Ensure timely and equitable access to medicines for patients across the EU Address other ongoing issues, including antimicrobial resistance and environmental impact of medicines. analysis (Source: L.E.K)

Labelling 90

Labelling Documentation 90

Pharmaceutical Technology

FEBRUARY 16, 2023

The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. Ophthalmic technology firm Eyenovia and Formosa Pharmaceuticals have entered a collaboration agreement to develop new ophthalmic therapeutics.

FDA 59

FDA 59

pharmaphorum

SEPTEMBER 2, 2019

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing environment in Europe has become increasingly challenging over the years. Innovative contracting has since become a common route to overcome these challenges and ensure timely access for patients.

52

52

Pharmaceutical Technology

OCTOBER 18, 2022

Moderna has entered an agreement with Gavi, the Vaccine Alliance, with regard to the delivery of Covid-19 vaccines to lower-income countries supported by the Gavi COVAX Advance Market Commitment (AMC). Topic sponsors are not involved in the creation of editorial content. 5 Omicron-targeting bivalent booster vaccine for Covid-19.

Vaccines 52

Vaccines 52

Pharma Marketing Network

FEBRUARY 16, 2021

These companies had to make a quick turnaround and transfer all of their in-person information into digital materials that could be easily accessible online for their attendees. First, think about the topic you plan to discuss, then map out exactly how the topic will be discussed and presented to your audience.

Communication 98

Communication 98

Board Vitals - Pharmacist

AUGUST 12, 2023

Preparing for the OBGYN board exam is a rigorous process that demands a strategic approach and access to reliable resources. This book also has over 1000 review questions to keep you sharp on many topics found on the OB/GYN Board Exam. No matter what your study style is, there is a resource available to help you prepare for the exam.

52

52

European Pharmaceutical Review

OCTOBER 5, 2023

What are the key topics you plan to cover during your session at CPHI Barcelona? Specifically, I’ll address strategies to enhance the affordability and accessibility of these therapies to broader populations. What recommendations do you have for expediting the product pipeline to market?

Immunization 91

Immunization 91

Pharmaceutical Technology

DECEMBER 12, 2022

The development, clinical trial and marketing expenses for the cell therapy will be shared by the companies while co-commercialising the product and equally splitting profits from the US region. Kite will oversee the marketing of the product outside the US while Arcellx is eligible for royalty payments on sales. Free Whitepaper.

Communication 105

Communication 105

Pharmaceutical Technology

APRIL 17, 2023

We believe having access to the public markets will help enable us to fund our clinical development in advanced neurodegenerative diseases and support the launch of our off-the-shelf allogenic programme in oncology.” Topic sponsors are not involved in the creation of editorial content.

98

98

PharmaShots

JANUARY 23, 2023

Until recently, there were very few topical options available for treating plaque psoriasis long-term. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. [i] of VTAMA cream?

FDA 40

FDA Labelling Immunization 40

ISPE

JULY 26, 2023

Global health authorities have been actively developing guidance and recommendations to mitigate disruptions in the supply chain, ensuring secure patient access to critical medicines. These include optimizing supply chain operations, lifecycle management, lab transformation, sustainable development, and navigating emerging markets.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 3, 2023

Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products. Dragitsch points out that working with a CMO can deliver a range of significant benefits and is key to providing a reliable supply to market.

Customer Service 52

Customer Service Documentation 52

pharmaphorum

JUNE 3, 2021

This article appears in our digital magazine Deep Dive: Market Access 2021. NICE also consulted on topic selection as well as a case for change for methods for health technology evaluation. Lots of buzzwords feature: flexible, agile, robust, future proof, rapid access.

Documentation 98

Documentation 98

pharmaphorum

MARCH 10, 2017

2017 is once again a year of significant change for pharma market access in Europe, with affordability on the agenda for almost every country in the region. Join our webinar to hear from experts in industry and healthcare discussing the challenges and solutions of access in the changing European market.

52

52

Pharmaceutical Technology

NOVEMBER 29, 2022

TCR-Ts can detect intracellular targets such as cancer-specific mutations to unlock targets which were not accessible earlier using cell therapies. The takeover will offer AstraZeneca access to TCR-Ts, which possess the potential for fighting solid tumours. Topic sponsors are not involved in the creation of editorial content.

Communication 111

Communication 111

pharmaphorum

NOVEMBER 22, 2016

Key topics to be discussed include: – The burden of HCV – The current market landscape – The current patient access model and its impact on budget – Cost efficiencies shown by modelling – Cure versus lifetime treatment costs

52

52

Pharmaceutical Technology

JANUARY 5, 2023

Capsida Biotherapeutics CEO Peter Anastasiou said: “Prevail’s expertise in neuroscience, gene therapy R&D, and access to Lilly’s world-class commercialization capabilities complements Capsida’s fully integrated approach, including our next-generation AAV engineering platform. Free Whitepaper.

Communication 95

Communication 95

pharmaphorum

SEPTEMBER 21, 2020

Sharecare says its content covers healthcare topics “from A to Z” and has been curated from healthcare providers, non-profit organisations, and academic institutions. billion at the end of 2018, according to market research. Amazon meanwhile has made no secret of its ambitions in healthcare, and not just as a content channel.

Mayo Clinic 138

Mayo Clinic HIPAA Insurance 138

pharmaphorum

AUGUST 18, 2022

“Now the conversation has moved on in [recent] years more to how could these get reimbursed and how are they regulated and how do we get them to market? Patient centricity is important in every aspect of care, but the nature of digital therapeutics makes the topic especially germane, Coder says. “I’m

98

98

Pharmaceutical Technology

MAY 17, 2023

While negotiating drug prices is common practice in other major markets, CMS had not previously held the legal authority to do so. Insulin affordability has continued to prove a hot button topic as major pricing reforms are on the way.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52